Importantly, immunofluorescence analysis revealed that neomycin treatment substantially reduced the infiltration of CD206+ M2-like macrophages in the tumor microenvironment (Figure 4I), indicating a reversal of the immunosuppressive state. The gene discussed is MRC1; the disease is neoplasm.